Close
Login to MyACC
ACC Members


Not a Member?

The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.

Join ACC

182 Results

Resource Listings

Articles

International Comparative Legal Guide to Digital Health 2024

By Global Legal Group

This guide provides corporate counsel and international practitioners with comprehensive jurisdiction-by-jurisdiction guidance to digital health laws and regulations around the world.

Topics covered include digital health technologies, data use, data sharing, intellectual property, commercial agreements, AI and machine learning, and liability.

Articles

Three Considerations for Health Care Providers After the Dobbs Decision

By Claire Marblestone, Foley Lardner

Health care providers that provide a full spectrum of women’s health care services, including abortion, will need to understand how the Dobbs decision impacts the care they can provide to patients. Absent a federal protection of a patient’s ability to obtain an abortion, providers operating in this space will need to understand the scope of State laws that apply to abortion services.

Articles

Software as a Medical Device: Challenges Facing the Industry

By Kyle Y. Faget, Nathan A. Beaver, Jessa Boubker, Thomas B. Ferrante, Rachel B. Goodman, Eric L. Sophir, Nicholas J. Zepnick, Austin J. Kim (Foley & Lardner LLP)

The intersection of software, technology and health care and the proliferation of software as a medical device in the health care arena has become common place and has spurred significant innovations. This article discusses legal and regulatory considerations related to Software as a Medical Device (SaMD).

Articles

Building Biotech with Brains: Strategies for Maximizing Value of AI-Driven Biotechnology Inventions

By Aashish R. Karkhanis, Jeffrey Simon

The rapid rise of artificial intelligence (AI) and machine learning (ML) in biotechnology products and services is becoming a driver of the personalized medicine and health care sectors. While this integration can require special consideration during development of a patent portfolio, stakeholders across engineering, legal, and executive teams in both established companies and start-ups can leverage it to create valuable intellectual property (IP) assets in the marketplace.

ACC

This site uses cookies to store information on your computer. Some are essential to make our site work properly; others help us improve the user experience.

By using the site, you consent to the placement of these cookies. For more information, read our cookies policy and our privacy policy.

Accept